Clinical Trial

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-07; most recent amendment 2025-05-07.
Status change: Active, Not Recruiting → Recruiting 2024-05-14
Status change: Recruiting → Active, Not Recruiting 2023-09-13
Trial Details
NCT Number NCT05946785
Lead Sponsor Anna Stanhewicz, PhD
Conditions Gestational Diabetes, Vascular Endothelial Function
Enrollment 28 participants
Start Date 2023-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29